BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 8, 2025
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
PSP94 suppresses prostate cancer growth in mouse model
Feb. 12, 1999
No Comments
Enrollment completed in Maxim's malginant melanoma phase III trial
Feb. 9, 1999
No Comments
Ligand receives FDA approval for Ontak as CTCL treatment
Feb. 8, 1999
No Comments
ImmunoGen and SB enter agreement for colorectal cancer treatment
Feb. 4, 1999
No Comments
Phase I clinical trial of novel cervical dysplasia Rx from StressGen
Feb. 3, 1999
No Comments
SWOG phase II study of safety and efficacy of rhIL-4 in malignant melanoma
Jan. 25, 1999
No Comments
Polish authorities allow phase II testing of Multikine
Jan. 15, 1999
No Comments
Health Canada approves new indication for Proleukin
Jan. 12, 1999
No Comments
Proleukin receives orphan drug status for two new indications
Jan. 7, 1999
No Comments
Anticancer immunotoxin available for licensing from NIH
Jan. 4, 1999
No Comments
Previous
1
2
…
910
911
912
913
914
915
916
917
918
…
949
950
Next
RSS